Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin (Q44473101)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin |
scientific article |
Statements
1 reference
Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin (English)
1 reference
Anna Berkenblit
1 reference
Nadine Tung
1 reference
Young Kim
1 reference
Heidi Feyler
1 reference
Jonathan Niloff
1 reference
Karen Van Den Berghe
1 reference
Stephen A Cannistra
1 reference
1 June 2003
1 reference
1 reference
89
1 reference
3
1 reference
486-493
1 reference
Identifiers
1 reference
1 reference